Wide range of phenotypic severity in individuals with late truncations unique to the predominant CDKL5 transcript in the brain. Keehan, L., Haviland, I., Gofin, Y., Swanson, L. C., El Achkar, C. M., Schreiber, J., VanNoy, G. E., O'Heir, E., O'Donnell-Luria, A., Lewis, R. A., Magoulas, P., Tran, A., Azamian, M. S., Chao, H., Pham, L., Samaco, R. C., Elsea, S., Thorpe, E., Kesari, A., Perry, D., Lee, B., Lalani, S. R., Rosenfeld, J. A., Olson, H. E., Burrage, L. C., & Network, U. D. American Journal of Medical Genetics Part A, 188(12):3516–3524, June, 2022. _eprint: https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajmg.a.62940
Wide range of phenotypic severity in individuals with late truncations unique to the predominant CDKL5 transcript in the brain [link]Paper  doi  abstract   bibtex   
Cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) is caused by heterozygous or hemizygous variants in CDKL5 and is characterized by refractory epilepsy, cognitive and motor impairments, and cerebral visual impairment. CDKL5 has multiple transcripts, of which the longest transcripts, NM_003159 and NM_001037343, have been used historically in clinical laboratory testing. However, the transcript NM_001323289 is the most highly expressed in brain and contains 170 nucleotides at the 3′ end of its last exon that are noncoding in other transcripts. Two truncating variants in this region have been reported in association with a CDD phenotype. To clarify the significance and range of phenotypes associated with late truncating variants in this region of the predominant transcript in the brain, we report detailed information on two individuals, updated clinical information on a third individual, and a summary of published and unpublished individuals reported in ClinVar. The two new individuals (one male and one female) each had a relatively mild clinical presentation including periods of pharmaco-responsive epilepsy, independent walking and limited purposeful communication skills. A previously reported male continued to have a severe phenotype. Overall, variants in this region demonstrate a range of clinical severity consistent with reports in CDD but with the potential for milder presentation.
@article{keehan_wide_2022,
	title = {Wide range of phenotypic severity in individuals with late truncations unique to the predominant {CDKL5} transcript in the brain},
	volume = {188},
	issn = {1552-4833},
	url = {https://onlinelibrary.wiley.com/doi/abs/10.1002/ajmg.a.62940},
	doi = {10.1002/ajmg.a.62940},
	abstract = {Cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) is caused by heterozygous or hemizygous variants in CDKL5 and is characterized by refractory epilepsy, cognitive and motor impairments, and cerebral visual impairment. CDKL5 has multiple transcripts, of which the longest transcripts, NM\_003159 and NM\_001037343, have been used historically in clinical laboratory testing. However, the transcript NM\_001323289 is the most highly expressed in brain and contains 170 nucleotides at the 3′ end of its last exon that are noncoding in other transcripts. Two truncating variants in this region have been reported in association with a CDD phenotype. To clarify the significance and range of phenotypes associated with late truncating variants in this region of the predominant transcript in the brain, we report detailed information on two individuals, updated clinical information on a third individual, and a summary of published and unpublished individuals reported in ClinVar. The two new individuals (one male and one female) each had a relatively mild clinical presentation including periods of pharmaco-responsive epilepsy, independent walking and limited purposeful communication skills. A previously reported male continued to have a severe phenotype. Overall, variants in this region demonstrate a range of clinical severity consistent with reports in CDD but with the potential for milder presentation.},
	language = {en},
	number = {12},
	urldate = {2022-11-16},
	journal = {American Journal of Medical Genetics Part A},
	author = {Keehan, Laura and Haviland, Isabel and Gofin, Yoel and Swanson, Lindsay C. and El Achkar, Christelle Moufawad and Schreiber, John and VanNoy, Grace E. and O'Heir, Emily and O'Donnell-Luria, Anne and Lewis, Richard Alan and Magoulas, Pilar and Tran, Alyssa and Azamian, Mahshid S. and Chao, Hsiao-Tuan and Pham, Lisa and Samaco, Rodney C. and Elsea, Sarah and Thorpe, Erin and Kesari, Akanchha and Perry, Denise and Lee, Brendan and Lalani, Seema R. and Rosenfeld, Jill A. and Olson, Heather E. and Burrage, Lindsay C. and Network, Undiagnosed Diseases},
	month = jun,
	year = {2022},
	note = {\_eprint: https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajmg.a.62940},
	keywords = {Alamut, Alamut Visual Plus v1.4, CDD, CDKL5},
	pages = {3516--3524},
}
Downloads: 0
About
Documentation
Keywords
Search
Users
Terms and Conditions of Use
Privacy Policy
Sitemap
© BibBase.org 2021